Clinical trial for Endometriosis
Official title Combined TECAR/EMS Therapy vs. Standard Manual Therapy for Endometriosis Pelvic Pain
ClinicalTrials.gov ID: NCT07933094
What this study is testing
- What it's testing
- This study compares two ways of delivering a combined radiofrequency (RET), muscle stimulation (Hi-EMS), and pulsed radiofrequency (Hi-TENS) therapy, hands-on by a physical therapist or hands-free using adhesive pads, and compares the combined therapy to hands-on manual therapy alone for pelvic pain in women with endometriosis.
- Time commitment: about 6 weeks
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only
You may be able to join if
- Women age 18 or older with a diagnosis of endometriosis (surgical/histologic or imaging-based)
- Pelvic pain attributable to endometriosis
- Able to attend the 8-session outpatient schedule
- Able to provide written informed consent
You likely can't join if
- Clinical concern for or diagnosis of May-Thurner syndrome with associated risk of deep vein thrombosis (DVT)
- Presence of a cardiac pacemaker, implantable cardioverter-defibrillator, or other active implanted electronic device
- Active or suspected deep vein thrombosis or other uncontrolled clotting disorder
- Open wound, active infection, or compromised skin integrity at planned electrode sites (suprapubic/lower abdominal region and sacral/gluteal region)
- Known malignancy in the region to be treated
- Current pregnancy
See the full eligibility criteria
- Women age 18 or older with a diagnosis of endometriosis (surgical/histologic or imaging-based)
- Pelvic pain attributable to endometriosis
- Able to attend the 8-session outpatient schedule
- Able to provide written informed consent
- Clinical concern for or diagnosis of May-Thurner syndrome with associated risk of deep vein thrombosis (DVT)
- Presence of a cardiac pacemaker, implantable cardioverter-defibrillator, or other active implanted electronic device
- Active or suspected deep vein thrombosis or other uncontrolled clotting disorder
- Open wound, active infection, or compromised skin integrity at planned electrode sites (suprapubic/lower abdominal region and sacral/gluteal region)
- Known malignancy in the region to be treated
- Current pregnancy
- Inability to tolerate electrical stimulation per participant report during device calibration
The study team makes the final eligibility decision.
Where it is enrolling
- Brooklyn, New York, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The study runs about 6 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Brooklyn, New York, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.